The Promise and Peril of Alzheimer Disease Prevention

Interventions to delay or prevent Alzheimer disease dementia hold the promise of sizable personal and public benefit. The nomenclature, research designs, and interpretation of results for studies assessing prevention outcomes, however, are inconsistent and would benefit from greater consensus about the necessary requirements for specific intervention claims. Moreover, the public space includes substantial media attention, direct-to-consumer diagnostics, and marketing of unproven interventions for brain health and dementia prevention. This article outlines these issues in hopes of catalyzing further consensus building and alerting professional and regulatory agencies to these topics.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2026-07-17
DOI
https://doi.org/10.1212/wnl.0000000000218348
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Promise and Peril of Alzheimer Disease Prevention

Jonathan Graff‐Radford, Joshua D. Grill
Neurology
Dementia and Cognitive Impairment Research
article

The Promise and Peril of Alzheimer Disease Prevention

Jonathan Graff‐Radford, Joshua D. Grill
article en

Abstract

Interventions to delay or prevent Alzheimer disease dementia hold the promise of sizable personal and public benefit. The nomenclature, research designs, and interpretation of results for studies assessing prevention outcomes, however, are inconsistent and would benefit from greater consensus about the necessary requirements for specific intervention claims. Moreover, the public space includes substantial media attention, direct-to-consumer diagnostics, and marketing of unproven interventions for brain health and dementia prevention. This article outlines these issues in hopes of catalyzing further consensus building and alerting professional and regulatory agencies to these topics.

NeurologyVol. 107(3)
University of California, Irvine (US), Mayo Clinic in Arizona (US)
Openalex Percentile: Top 8%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.